Skip to main content

Havens Advisors LLC

SEC CIK
0001280200
Latest filing
Jan 25, 2023

The latest 13F from Havens Advisors LLC covers Q4 2022 (filed Jan 25, 2023): 31 long positions worth $39.3M. The top 10 holdings make up 61.2% of the portfolio, and the largest is Cowen Inc. (COWN) at 8.8%. Livermore has 8 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q4 2022

Share counts compared with Q3 2022: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
14
Est. +$18.7M
Added
5
Est. +$4.43M
Reduced
6
Est. −$5.52M
Sold out
25
Est. −$43.7M

Top 5 holdings

Share of this quarter's portfolio value

  1. COWNCowen Inc.
    8.8%$3.48MHistory
  2. UMPQUmpqua Holdings Corp
    6.8%$2.69MHistory
  3. TSEMTower Semiconductor Ltd
    6.6%$2.61MHistory
  4. FHNFirst Horizon Corp
    6.6%$2.60MHistory
  5. RTORentokil Initial PLC
    6.3%$2.50MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. RTORentokil Initial PLC
    +$2.50MNewHistory
  2. HZNPHorizon Therapeutics Public Ltd Co
    +$2.39MNewHistory
  3. Sierra Wireless Inc826516106
    +$2.12MNew
  4. FHNFirst Horizon Corp
    +$2.01MAddedHistory
  5. AJRDAerojet Rocketdyne Holdings, Inc.
    +$1.96MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. RTORentokil Initial PLC
    +6.34 pp0.0% → 6.3%History
  2. HZNPHorizon Therapeutics Public Ltd Co
    +6.07 pp0.0% → 6.1%History
  3. FHNFirst Horizon Corp
    +5.78 pp0.8% → 6.6%History
  4. Sierra Wireless Inc826516106
    +5.38 pp0.0% → 5.4%
  5. COWNCowen Inc.
    +5.13 pp3.7% → 8.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ChemoCentryx, Inc.16383L106
    −$3.88MSold out
  2. TMXTerminix Global Holdings Inc
    −$3.80MSold outHistory
  3. YAlleghany Corp
    −$3.69MSold outHistory
  4. NLSNNielsen Holdings plc
    −$3.50MSold outHistory
  5. GBTGlobal Blood Therapeutics, Inc.
    −$3.13MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. ChemoCentryx, Inc.16383L106
    −5.80 pp5.8% → 0.0%
  2. TMXTerminix Global Holdings Inc
    −5.68 pp5.7% → 0.0%History
  3. YAlleghany Corp
    −5.53 pp5.5% → 0.0%History
  4. NLSNNielsen Holdings plc
    −5.24 pp5.2% → 0.0%History
  5. ROGRogers Corp
    −4.94 pp6.2% → 1.2%History

Metrics

13F metrics for Q4 2022, computed only from the numbers in the filings. Definitions below.

Portfolio value
$39.3M
−$27.5M (−41.1%) vs. prior quarter
Positions
31
−11 vs. prior quarter
Top 10 concentration
61.2%
Top 10 as share of value
Turnover
43.5%
Q4 2022, one quarter
Average holding period
2.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

8 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $126.0M (Q2 2021)

Q1 2021: $112.3MQ2 2021: $126.0MQ3 2021: $82.4MQ4 2021: $84.6MQ1 2022: $53.9MQ2 2022: $63.0MQ3 2022: $66.8MQ4 2022: $39.3M
Q1 2021Q4 2022
13F filings of Havens Advisors LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q4 2022Jan 25, 202331$39.3MCOWNUMPQTSEMvs. Q3 2022SEC
Q3 2022Oct 12, 202242$66.8MROGChemoCentryx, Inc.TMXvs. Q2 2022SEC
Q2 2022Aug 15, 202241$63.0MCoherent IncROGWBTvs. Q1 2022SEC
Q1 2022Apr 13, 202243$53.9MROGCoherent IncCERNvs. Q4 2021SEC
Q4 2021Jan 31, 202243$84.6MXLNXCoherent IncINFOvs. Q3 2021SEC
Q3 2021Oct 7, 202143$82.4MCoherent IncXLNXNUANvs. Q2 2021SEC
Q2 2021Jul 14, 202146$126.0MXLNXMXIMALXNvs. Q1 2021SEC
Q1 2021Apr 14, 202147$112.3MMXIMWORKCoherent Inc–SEC